Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122132) titled 'An Phase ? clinical study evaluating the safety and efficacy of Autologous Human Polyclonal Regulatory T Cell Injection (NP001 Cell Injection) in patients with Multiple System Atrophy' on April 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
Condition:
Multiple System Atrophy
Intervention:
SAD:NP001: Intrathecal re-infusion, single administration, with three dose cohorts (1.0, 3.0, and 9.0 x 10^7 regulatory T cells). If the Study Review Committee (SRC) determines that a pre-specified dose cohort meets the dose escalation stop...